Peter Wostyn

Peter Wostyn, MD, works in the Department of Psychiatry, Psychiatrisch Centrum Sint-Amandus, Beernem, Belgium and is a co-founder of P&X Medical, a biotech company focused on the treatment of intracranial pressure, cerebrospinal fluid turnover and glymphatic flow in neurodegenerative disorders, with a primary focus on glaucoma.

Dr Wostyn developed the unproven glymphatic dysfunction hypothesis which postulates that a dysfunction of the waste clearance system, called the glymphatic system, causes a build-up of toxins within the central nervous system, which he hypothesised precipitates at least some cases of ME/CFS.

Notable studies

• 2018, Can cerebrospinal fluid diversion be beneficial in the treatment of chronic fatigue syndrome?
• 2018, The putative glymphatic signature of chronic fatigue syndrome: A new view on the disease pathogenesis and therapy - (Abstract)

• 2019, Retinal nerve fiber layer thinning in chronic fatigue syndrome as a possible ocular biomarker of underlying glymphatic system dysfunction

See also

• Glymphatic dysfunction hypothesis

central nervous system (CNS) - One of the two parts of the human nervous system, the other part being the peripheral nervous system. The central nervous system consists of the brain and spinal cord, while the peripheral nervous system consists of nerves that travel from the central nervous system into the various organs and tissues of the body.

See myalgic encephalomyelitis.

See chronic fatigue syndrome.